MPP 89
2
Discover top-quality products tailored for scientific and medical research. Request a personalized quote today
to enhance your projects.
MPP 89 is a human malignant mesothelioma (MM) cell line that was isolated from pleural effusions in MM patients. This cell line maintains a distinctive spindle-like morphology and exhibits noteworthy ultrastructural features, including epithelioid elements with convoluted nuclei, finely dispersed chromatin, and prominent nucleoli. It is marked by an abnormal hyperdiploid karyotype with the absence of both chromosomes 17. Immunohistochemical analysis reveals positive staining for CAM 5.2, HBME-1, and Calretinin, whereas it shows negative staining for Z-CEA, LeuM1, LeuM6, and LeuM3.
Why choose MPP 89 from AcceGen?
MPP 89 from AcceGen boasts exceptional characteristics, including high viability and quality, meticulous incubation under optimal conditions, proficient cryopreservation, mycoplasma absence confirmed through real-time PCR assay, and identity verified via STR analysis.
| Product Code | MPP-89; MPP89 |
| Species | Human |
| Cat.No | ABC-TC0701 |
| Product Category | Tumor Cell Lines |
| Size/Quantity | 1 vial |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Biosafety Level | 2 |
| Storage | Liquid Nitrogen |
| Product Type | Human Mesothelioma Cell Lines |
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $100 coupon. Simply click here and submit your paper’s PubMed ID (PMID).
FOR RESEARCH USE ONLY
The MPP 89 cell line is a pivotal asset in the field of malignant mesothelioma research with multifaceted applications. It serves as a platform for the investigation and advancement of innovative therapeutic immunotherapies. Moreover, MPP 89 is instrumental in the precise assessment of microRNA (miRNA) expression profiles in mesothelioma, facilitating the identification of diagnostic and prognostic markers crucial for enhanced disease characterization, ultimately contributing to the refinement of diagnostic and therapeutic strategies.
